Application of an improved cerebroventricular perfusion technique in the rabbit: effects of pentobarbital or haloperidol on monoamine metabolites and proteins in the perfusate.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology*; D006719:Homovanillic Acid / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007276:Injections, Intraventricular / Q000379:methods*; D008297:Male; D010424:Pentobarbital / Q000494:pharmacology*; D010477:Perfusion / Q000379:methods; D011506:Proteins / Q000378:metabolism*; D011817:Rabbits; D013997:Time Factors
D001679:Biogenic Amines; D011506:Proteins; D006897:Hydroxyindoleacetic Acid; D010424:Pentobarbital; D006220:Haloperidol; D004298:Dopamine; D006719:Homovanillic Acid